Log in
Enquire now

List of Senex Biotechnology patents

List of Senex Biotechnology patents
List of Eutropics Pharmaceuticals patents
List of Blue Solutions patents
List of A.O. Smith patents
List of companies in Cathay Capital's investment portfolio
Companies in the Crypto-collateralized industry
Patents where
Current Assignee
Name
is
Senex BiotechnologySenex Biotechnology
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10584369 Cell-based methods for measuring activity of a protein inhibitor

Patent 10584369 was granted and assigned to Senex Biotechnology on March, 2020 by the United States Patent and Trademark Office.

Senex Biotechnology
Senex Biotechnology
Senex Biotechnology
Senex Biotechnology
United States Patent and Trademark Office
United States Patent and Trademark Office
10584369
March 10, 2020
‌
US Patent 9321737 CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer

Patent 9321737 was granted and assigned to Senex Biotechnology on April, 2016 by the United States Patent and Trademark Office.

Senex Biotechnology
Senex Biotechnology
Senex Biotechnology
Senex Biotechnology
United States Patent and Trademark Office
United States Patent and Trademark Office
9321737
April 26, 2016
‌
US Patent 9409873 CDKI pathway inhibitors and uses thereof

Patent 9409873 was granted and assigned to Senex Biotechnology on August, 2016 by the United States Patent and Trademark Office.

Senex Biotechnology
Senex Biotechnology
Senex Biotechnology
Senex Biotechnology
United States Patent and Trademark Office
United States Patent and Trademark Office
9409873
August 9, 2016
‌
US Patent 10993945 CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer

Patent 10993945 was granted and assigned to Senex Biotechnology on May, 2021 by the United States Patent and Trademark Office.

Senex Biotechnology
Senex Biotechnology
Senex Biotechnology
Senex Biotechnology
United States Patent and Trademark Office
United States Patent and Trademark Office
10993945
May 4, 2021
‌
US Patent 8598344 CDKI pathway inhibitors and uses thereof

Patent 8598344 was granted and assigned to Senex Biotechnology on December, 2013 by the United States Patent and Trademark Office.

Senex Biotechnology
Senex Biotechnology
United States Patent and Trademark Office
United States Patent and Trademark Office
8598344
December 3, 2013
‌
US Patent 8592147 High-content screening for drugs against cancer and age-related diseases

Patent 8592147 was granted and assigned to Senex Biotechnology on November, 2013 by the United States Patent and Trademark Office.

Senex Biotechnology
Senex Biotechnology
United States Patent and Trademark Office
United States Patent and Trademark Office
8592147
November 26, 2013
6 results
0 selected
6 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us